GLOW
70mg
A GHK-Cu / BPC-157 / TB-500 research blend for multi-pathway cellular studies.
Bundle & save
Strength
- Ships in 24 hours
- HPLC & endotoxin verified
- Encrypted checkout
Research details
Areas of research interest
GLOW combines three peptides studied in tissue-repair research. GHK-Cu is studied mainly in skin regeneration and wound healing, BPC-157 in tendon, ligament, and gastrointestinal models, and TB-500 in wound-healing and cardiac models. The blend is most often discussed in connection with skin and soft-tissue repair. None of the three peptides is approved by FDA for any use.
Overview
Each vial contains GHK-Cu (a copper-binding tripeptide), BPC-157 (a synthetic 15-amino-acid peptide), and TB-500 (a synthetic version of an active region of thymosin beta-4). See the individual product pages for each compound's background.
Research summary
Combination data. No published study has tested this three-peptide combination. The only published study combining BPC-157 and TB-500 found no added benefit over either peptide alone in a rat tendon model [1].
Component research. GHK-Cu increased collagen, elastin, and glycosaminoglycan synthesis in laboratory studies [2]. BPC-157 improved healing in a rat Achilles transection model [3], and thymosin beta-4 accelerated wound closure in a rat full-thickness wound model [4].
References
- 1. Biçer O, et al. Jt Dis Relat Surg. 2026;37(3):822–837. doi: 10.52312/jdrs.2026.2951
- 2. Pickart L, Margolina A. Int J Mol Sci. 2018;19(7):1987. PMID: 29986520
- 3. Staresinic M, et al. J Orthop Res. 2003;21(6):976–983. PMID: 14554208
- 4. Malinda KM, et al. J Invest Dermatol. 1999;113(3):364–368. PMID: 10469335
For laboratory research use only. Not for human or veterinary use. This product is not a drug, food, cosmetic, or dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA.